Posted on Tuesday 19 March 2019 by John Mulgrew
A Belfast firm is to join a handful of Northern Ireland companies to list on the London Stock Exchange.
Diaceutics will be the fourth Northern Ireland firm to list. It’s due to begin trading on the AIM market, with an initial stock floating of £53m. The company has conditionally raised £17m.
Diaceutics, which was set up by Peter Keeling, works closely with the pharmaceutical industry to help tailor medical treatments, and earlier this year announced it would open a new hub in Singapore.
Since its inception in 2005, Diaceutics has focused on the “diagnostic testing market, collating large amounts of laboratory, patient (on an anonymised and aggregated basis), claims and data which it uses to deliver diagnostic testing strategies to its clients”.